PASSANTINO, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 388
EU - Europa 252
AS - Asia 39
Totale 679
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 388
IE - Irlanda 74
PL - Polonia 59
SE - Svezia 56
IT - Italia 49
JO - Giordania 13
HK - Hong Kong 12
CH - Svizzera 7
CN - Cina 5
VN - Vietnam 5
IN - India 3
RU - Federazione Russa 2
DE - Germania 1
FR - Francia 1
GB - Regno Unito 1
PT - Portogallo 1
SG - Singapore 1
UA - Ucraina 1
Totale 679
Salva come PNG Salva come JPEG
Città #
Dublin 74
Warsaw 56
Fairfield 55
Ashburn 42
Chandler 39
Wilmington 24
Seattle 20
Lawrence 19
Altamura 18
Woodbridge 18
Cambridge 17
Houston 17
Florence 14
Buffalo 12
Princeton 12
Boston 10
Ann Arbor 8
Bern 7
Beijing 5
Dong Ket 4
Hillsboro 4
San Diego 4
Andover 3
Medford 3
Naples 3
Boardman 2
Falls Church 2
Prato 2
Pune 2
Salerno 2
Siena 2
Washington 2
Bruino 1
Chennai 1
Clifton 1
Duncan 1
Frankfurt am Main 1
Genova 1
Hanoi 1
London 1
Mem Martins 1
Milan 1
Monte San Savino 1
Norwalk 1
Singapore 1
Totale 515
Salva come PNG Salva come JPEG
Nome #
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events 105
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 103
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy 66
Impact of cardiovascular involvement on the clinical course of paediatric mitochondrial disorders 58
Cardiomyopathies in children – inherited heart muscle disease: Overview of hypertrophic, dilated, restrictive and non-compaction phenotypes 51
P2316Outcome of septal reduction therapies for obstructive hypertrophic cardiomyopathy in a high-flow referral centre with moderate volume procedural programmes 49
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 38
Predictive value of classic sudden death risk factors in pediatric-onset hypertrophic cardiomyopathy 38
Genetic basis of pediatric sarcomeric hypertrophic cardiomyopathy: impact on long term outcome 35
Hidden familial cardiomyopathies in children: Role of genetic testing 27
Clinical presentation and long-term outcomes of infantile hypertrophic cardiomyopathy: a European multicentre study 23
Clinical profile and outcome of cardiomyopathies in infants and children seen at a tertiary centre 22
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy 18
Clinical Exome Sequencing Revealed a De Novo FLNC Mutation in a Child with Restrictive Cardiomyopathy 17
Clinical pathway for cardiomyopathies: A genetic testing strategy proposed by ANMCO in Tuscany 16
Indicazioni all’esecuzione del test genetico nella diagnosi delle cardiomiopatie ad esordio pediatrico: percorso clinico della Società Italiana di Cardiologia Pediatrica 13
Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions 13
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 9
Totale 701
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.514
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20196 0 0 0 0 0 2 0 2 0 0 2 0
2019/2020117 1 0 0 5 9 13 22 20 18 9 12 8
2020/2021120 9 13 10 15 5 6 4 11 10 26 5 6
2021/202271 0 4 4 2 2 2 2 5 11 2 16 21
2022/2023302 21 64 17 1 20 54 44 21 37 4 10 9
2023/202472 2 16 22 3 9 20 0 0 0 0 0 0
Totale 701